bendamustine hydrochloride has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arranz, R; Calleja, M; Cánovas, A; Cervera, JM; de la Fuente, I; de Oña, R; Domingo, E; Gironella, M; Gorosquieta, A; Grande, C; Guillén, H; Lopez-Lorenzo, JL; Marin, M; Medina, A; Mencha, C; Panizo, C; Peñalver, FJ; Perez, I; Perez, R; Prieto, E; Ramila, E; Salar, A; Sanchez-Gonzalez, B; Sancho, JM; Sebastian, E | 1 |
| Engelhardt, M; Hieke, S; Horn, J; Kleber, M; Schmitt-Gräff, A; Wäsch, R | 1 |
2 other study(ies) available for bendamustine hydrochloride and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Compassionate Use Trials; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Invasiveness; Nitrogen Mustard Compounds; Retrospective Studies; Spain; Treatment Outcome | 2012 |
Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Tolerance; Female; Follow-Up Studies; Frail Elderly; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Invasiveness; Nitrogen Mustard Compounds; Rituximab; Survival Rate; Treatment Outcome | 2012 |